Larvol Delta - BiomX-Receives-Orphan-Drug-Designation-from-the-US-Food-and-Drug-Administration-for-BX004-for-the-Treatment-of-Chronic-Pulmonary-Infection-Caused-by-Pseudomonas-aeruginosa-in-Patients-with-Cystic-Fibrosis

BX004 - BiomX

https://www.globenewswire.com/news-release/2024/01/04/2803947/0/en/BiomX-Receives-Orphan-Drug-Designation-from-the-U-S-Food-and-Drug-Administration-for-BX004-for-the-Treatment-of-Chronic-Pulmonary-Infection-Caused-by-Pseudomonas-aeruginosa-in-Pati.html

Jan 4, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next